Cargando…
Clinicopathological characteristics and prognosis of early-stage HER2 low-expression breast cancer: A single-center retrospective study
BACKGROUND: Owing to the emergence of drugs targeting human epidermal growth factor receptor 2 (HER2), remarkable prognostic enhancement has been seen for patients with HER2-positive breast carcinoma. However, anti-HER2 medicines are applicable merely to individuals with HER2-positive tumors, and th...
Autores principales: | Liu, Chang-Gen, Li, Yi-Fan, Ma, Tian-Yi, Lv, Meng, Lv, Zhi-Dong, Wang, Yuan-Yuan, Liu, Xiang-Ping, Mao, Yan, Wang, Hai-Bo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10090461/ https://www.ncbi.nlm.nih.gov/pubmed/37064133 http://dx.doi.org/10.3389/fonc.2023.1130734 |
Ejemplares similares
-
Clinicopathological Characteristics and Prognosis of HER2-Low Early-Stage Breast Cancer: A Single-Institution Experience
por: Xu, Hangcheng, et al.
Publicado: (2022) -
Malignant Myoepithelioma of the Head and Neck: Demographics, Clinicopathological Characteristics, Treatment, and Prognosis
por: Wang, Jia-Qi, et al.
Publicado: (2022) -
Clinicopathological characteristics of gastrointestinal schwannomas: A retrospective analysis of 78 cases
por: Peng, Hailing, et al.
Publicado: (2022) -
Analysis of the clinicopathological characteristics and prognosis of triple-positive breast cancer and HER2-positive breast cancer—A retrospective study
por: Ma, Dongxu, et al.
Publicado: (2023) -
Clinicopathological characteristics and outcome of primary sarcomatoid carcinoma of the gallbladder
por: Zou, Rui-Qi, et al.
Publicado: (2022)